Stakeholders now have until Oct. 6 to share their thoughts on the proposed FDA rule. Read More
The meeting will be a hybrid event, with the option to attend virtually. Read More
The company did not demonstrate that the product’s benefit outweighs the risks. Read More
Tobacco Control Act allows FDA to require manufacturers submit comparative health risk data.Read More
Second Circuit Appeals Court Rules for FDA
Magellan failed to show the product would benefit adult users outweighing youth risk.Read More
The FDA plans to have 100 percent of covered applications acted on by Dec. 31. Read More
CTP created a fact sheet to help amend applications and a video to help navigate the CTP portal.Read More
Judges agree the FDA changed decision-making criteria after PMTA submissions were made.Read More
The FDA said the company did not demonstrate its menthol products provide an added benefit over tobacco flavors.Read More
The application now moves on to a preliminary scientific review. Read More
Recent Posts
- No Significant Respiratory Symptoms Among Vapers: Study
- Pouch Nicotine Limits will Drive Users to Smoking: Tholos
- China Tobacco Deputy Head Expelled From Party
- Consumer Files Suit for Alleged Overcharging for Zyn
- Imperial Releases Full-Year Results
- New Surgeon General’s Report Addresses Disparities
- Kazakhstan Urged to Reconsider Policies
- IKE Tech, Ispire to File PMTA for Age Gating Technology
- Transition to Safer Products Underway: Report
- Thailand Launches Track-and-Trace System
- Tucker Carlson Launches Nicotine Pouch
- Marijuana More Popular in U.S. Than Cigarettes: Poll
- Robert Kennedy, Jr. Tapped to Lead Trump’s HHS
- Sweden Achieves ‘Smoke Free’ Status
- 22nd Century Net Loss Widens